Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.
The efficacy of flu shots is not always the same and its not always optimal. Some years, they can reduce the risk of illness by as little as 20% to 30%.
Subscribe to read this story ad-free
Get un… [+5583 chars]
Subscribe to read this story ad-free
Get un… [+5583 chars]